Literature DB >> 23647852

Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.

M J Huchko1, V G Woo, T Liegler, H Leslie, K Smith-McCune, G F Sawaya, E A Bukusi, C R Cohen.   

Abstract

OBJECTIVE: We sought to examine the impact of the loop electrosurgical excision procedure (LEEP) on the rate and magnitude of HIV-1 genital shedding among women undergoing treatment for cervical intraepithelial neoplasia 2/3 (CIN2/3).
DESIGN: Prospective cohort study. POPULATION: Women infected with HIV-1 undergoing LEEP for CIN2/3 in Kisumu, Kenya.
METHODS: Participants underwent specimen collection for HIV-1 RNA prior to LEEP and at 1, 2, 4, 6, 10, and 14 weeks post-LEEP. HIV-1 viral load was measured in cervical and plasma specimens using commercial real-time polymerase chain reaction (PCR) assays, to a lower limit of detection of 40 copies per specimen. MAIN OUTCOME MEASURES: Presence and magnitude of HIV-1 RNA (copies per specimen or cps) in post-LEEP specimens, compared with baseline.
RESULTS: Among women on highly active antiretroviral therapy (HAART), we found a statistically significant increase in cervical HIV-1 RNA concentration at week 2, with a mean increase of 0.43 log10 cps (95% CI 0.03-0.82) from baseline. Similarly, among women not receiving HAART, we found a statistically significant increase in HIV-1 shedding at week 2 (1.26 log10 cps, 95% CI 0.79-1.74). No other statistically significant increase in concentration or detection of cervical HIV-1 RNA at any of the remaining study visits were noted.
CONCLUSIONS: In women infected with HIV undergoing LEEP, an increase in genital HIV shedding was observed at 2 but not at 4 weeks post-procedure. The current recommendation for women to abstain from vaginal intercourse for 4 weeks seems adequate to reduce the theoretical increased risk of HIV transmission following LEEP.
© 2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2013 RCOG.

Entities:  

Keywords:  Cervical dysplasia; HAART; HIV; Kenya; genital shedding

Mesh:

Substances:

Year:  2013        PMID: 23647852      PMCID: PMC3739995          DOI: 10.1111/1471-0528.12258

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  15 in total

1.  Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.

Authors:  S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

2.  Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Authors:  Susan M Graham; Sarah E Holte; Norbert M Peshu; Barbra A Richardson; Dana D Panteleeff; Walter G Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra N Mandaliya; Julie M Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2007-02-19       Impact factor: 4.177

3.  Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.

Authors:  James E Cummins; Logan Christensen; Jeffery L Lennox; Timothy J Bush; Zhiwei Wu; Daniel Malamud; Tammy Evans-Strickfaden; Aladin Siddig; Angela M Caliendo; Clyde E Hart; Charlene S Dezzutti
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

4.  Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women.

Authors:  Victoria G Woo; Craig R Cohen; Elizabeth A Bukusi; Megan J Huchko
Journal:  Obstet Gynecol       Date:  2011-09       Impact factor: 7.661

5.  Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration.

Authors:  T C Wright; S Subbarao; T V Ellerbrock; J L Lennox; T Evans-Strickfaden; D G Smith; C E Hart
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

6.  Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3.

Authors:  Michael H Chung; Kevin P McKenzie; Barbra A Richardson; Grace C John-Stewart; Robert W Coombs; Hugo De Vuyst; Julia W Njoroge; Evans Nyongesa-Malava; Samah R Sakr; Nelly R Mugo
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

7.  Women's autonomy and timing of most recent sexual intercourse in Sub-Saharan Africa: a multi-country analysis.

Authors:  Michelle J Hindin; Carie J Muntifering
Journal:  J Sex Res       Date:  2011-05-24

8.  Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.

Authors:  L J Bollen; S P Tjong-A-Hung; J van der Velden; B W Mol; F W ten Kate; J ter Schegget; O P Bleker
Journal:  Gynecol Oncol       Date:  1999-02       Impact factor: 5.482

9.  Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding.

Authors:  F Zara; R E Nappi; R Brerra; R Migliavacca; R Maserati; A Spinillo
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

10.  Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.

Authors:  A Aerssens; P Claeys; E Beerens; A Garcia; S Weyers; L Van Renterghem; M Praet; M Temmerman; R Velasquez; C A Cuvelier
Journal:  Cytopathology       Date:  2008-05-28       Impact factor: 2.073

View more
  2 in total

1.  Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.

Authors:  Sharon A Greene; Christine J McGrath; Dara A Lehman; Kara G Marson; T Tony Trinh; Nelly Yatich; Evans Nyongesa-Malava; Catherine Kiptinness; Barbra A Richardson; Grace C John-Stewart; Hugo De Vuyst; Samah R Sakr; Nelly R Mugo; Michael H Chung
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

2.  Cervical Cancer Screening in HIV-Positive Women in India: Why, When and How?

Authors:  Amulya Boddu; Neerja Bhatla; Shachi Vashist; Sandeep Mathur; Reeta Mahey; Jayashree Natarajan; Ria Malik; Perumal Vanamail; Shweta Rai; Aruna Kumari; Lalit Dar; Naveet Wig
Journal:  J Obstet Gynaecol India       Date:  2021-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.